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A B S T R A C T
Previously we have shown in rats a new method of urine collection, hydrophobic sand, to be an acceptable
alternate in place of the traditional method using metabolic cages. Hydrophobic sand is non-toxic, induces
similar or lower levels of stress in the rat, and does not contaminate clinical urine markers nor metal con-
centrations in collected samples (Hoffman et al., 2017 and 2018). Urine is often used in humans and many
animal models as a readily-attainable biosample which contains proteins and microRNAs (miRNAs) within ex-
tracellular vesicles (EVs) that can be isolated to indicate changes in health. In order to ensure hydrophobic sand
did not in any way contaminate or disrupt the extraction and analysis of these EVs and miRNAs, we used urine
samples from the same 8 rats in the within-subjects crossover experiment comparing hydrophobic sand and
metabolic cage collection methods. We isolated EVs and miRNAs from the urine set and examined their quantity
and quality between the urine collection methods. We found no significant differences in particle size, particle
concentration, total RNA, or the type and abundance of miRNAs contained within the urine EVs due to urine
collection method, suggesting hydrophobic sand represents an easy-to-use, non-invasive method to collect ro-
dent urine for EVs and biomarker studies.
1. Introduction
Exosomes are a type of small, membrane-bound extracellular ve-
sicles (EVs) that may contain protein, mRNA, and microRNA (miRNA).
Exosomes are released by most cells and can be isolated from biofluids
such as serum and urine, which has sparked interest in their use as
potential non-invasive diagnostic biomarkers for various diseases [1–5].
In humans, exosomes have recently been linked to a number of diseases,
including nephronophthisis-related ciliopathies [6], diabetic kidney
disease [7], bladder cancer [8,9], liver disease [10], and amyotrophic
lateral sclerosis from cerebrospinal fluid [11]. Rat models of renal
disease, such as polycystic kidney disease (PKD), show similar devia-
tions in kidney health biomarkers as humans with PKD. In one study
this included increases of urea, guanidinosuccinic acid, creatinine,
guanidine, methylguanidine, and N(G)N(G)-dimethylarginine [12], and
another study found elevated expression levels of activator of G-protein
signaling 3 (AGS3) in urine exosomes for rat and humans with PKD
compared to controls [13]. These studies highlight the importance of
improving methods of isolating and using extracellular vesicles from
humans and animals for the study of disease.
In humans, urine collection is straightforward and standard. In ro-
dents, there are several available methods, but one acceptable standard
is the use of a metabolic cage, where rats are isolated in a small, circular
plastic cage with a wire mesh bottom that allows urine and feces to pass
through into separate collection tubes. Although isolation and collec-
tion times can vary, they are usually limited to 24 h. Habituation of the
animal to the metabolic cage is often required and its use must be
justified due to its potential for causing stress to the animal [14–17].
Previously we investigated the use of a new method for rat urine col-
lection, hydrophobic sand (brand name LabSand for scientific use).
Originally developed for home urine collection in the cat, LabSand is a
biodegradable material with a non-toxic hydrophobic coating that
causes urine to pool on its surface, making it easy to collect. We re-
ported no significant differences in stress induction, toxicity to the
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animals, urine volume collection, or urine quality with several common
clinical biomarkers [18], as well as sample integrity when assessing
potential contamination during urinary metal concentration analyses
[19]. Unlike the metabolic cage, hydrophobic sand is similar to home
cage bedding, reducing animal stress and does not require as much time
for collection or habituation [discussed in depth in our previous pub-
lications, 18 and 19]. Thus we concluded hydrophobic sand has the
potential to become a valuable new method for urine collection in the
rodent. Given the potential for EVs and miRNAs collected from urine to
act as important biomarkers for health conditions in a multitude of
research areas, our goal in the work presented here was to take the
method comparison a step further and determine if the quantity and
quality of EVs collected from rat urine by hydrophobic sand were
comparable to that of urine collected by metabolic cage. If we did not
find any differences in characterization of EVs and miRNAs collected
from urine via these two methods, it would indicate that hydrophobic
sand does not contaminate biosamples and thus would be an appro-
priate alternate method applicable to a broad range of research utilizing
urine samples.
2. Materials and methods
2.1. Animals
All animals in this study are the same as those previously reported in
detail [18]. No changes to animal manipulation or urine collection were
made for the purposes of this paper. Briefly, 8 male Sprague Dawley rats
(Envigo, Frederick, MD, USA) were maintained on a 12:12 light:dark
cycle with access to food and water ad libitum and pair-housed except
during urine collection periods. Rats underwent no treatment or ex-
perimental conditions beyond exposure to both urine collection
methods. All procedures involving animals were approved by the AFRRI
Institutional Animal Care and Use Committee under protocol 2016–05-
006.
2.2. Urine collection and experimental design
A crossover within-subjects design was used to compare urine col-
lection from traditional metabolic cages and hydrophobic sand
(LabSand, Coastline Global, Palo Alto, CA, USA) [full design and
method details can be found in 18]. Briefly, rats were randomly as-
signed to two groups: (A) metabolic cage followed by LabSand or (B)
LabSand followed by the metabolic cage. Both groups were run si-
multaneously under the same testing conditions. There was a total of 5
collection sessions: at 2 h, at 4 h, and three separate 6 h sessions, each
separated by a rest period of at least 48 h. The method crossover oc-
curred after the last session and the entire pattern was repeated. Food
and water were not provided to any animal during urine collection
sessions, but each animal was provided with a water replacement gel in
a plastic cup (HydroGel®, Clear H2O, Westbrook, ME, USA) to avoid
dilution from a water bottle drip.
For the metabolic cage method, animals were individually housed in
a standard circular metabolic cage (Nalgene Nunc, Rochester, NY, USA)
with a wire mesh floor where urine collected into a Nalgene tube at the
bottom of a funnel system. Urine could only be collected at the end of
the session due to the cage design. For the hydrophobic sand method,
animals were individually housed in a rectangular microisolator cage
with the sand lining the bottom of the cage in place of regular bedding;
urine pools on top of the sand, which is then collected with a pipette.
For each rat, we collected urine every half hour which was subse-
quently pooled at the end of the session. The urine collected in [18] was
also analyzed in [19] and an aliquot of the same urine samples were
used here for EV isolation and analysis.
2.3. Extracellular vesicle isolation and characterization
The experimental design of n=8 rats with a within-subjects
crossover design (4 in hydrophobic sand, 4 in metabolic cages for 5
collection sessions, then the groups switched for an additional 5 ses-
sions) provided an n=8 for each session of each collection method. In
order to have enough volume to collect extracellular vesicles from each
rat, we created a pooled sample (3mL total) of all 5 sessions within
each individual rat's method of urine collection; this gives an n=8
total urine samples collected by each method. Extracellular vesicles
were isolated using ExoQuick-TC kit according to the manufacturer's
protocol (System Biosciences, Palo Alto, CA, USA). Urine EV size and
abundance were measured using nanoparticle tracking analysis (NTA)
with ZetaView PMX 110 (Particle Metrix, Meerbusch, Germany) and
corresponding software 8.04.02 sp1. After calibration using 100 nm
polystyrene particles, EVs were appropriately diluted using Dulbecco's
Phosphate-Buffered Saline (Thermo Fisher, Waltham, MA, USA) to
measure the particle size and concentration. NTA measurements were
analyzed at 11 positions at a constant temperature of 23 °C.
2.4. miRNA microarray analysis and quantification of select miRNA
expression by qPCR
A total of 150 ng of RNA isolated from the EVs was pooled from all
samples within each urine collection method to conduct a survey of
microRNA abundance using microarray analysis. The microarray hy-
bridization and processing were performed at the University of
Kentucky Genomic Core Laboratory using Affymetrix miRNA 4.0 array
chips (Santa Clara, CA, USA). Raw signal intensity data were normal-
ized with robust multi-array average (RMA) from the Affymetrix data
bank and sorted from highest to lowest signal using the LabSand group.
RNA from individual samples was then used to validate the five
most abundant miRNAs as determined by microarray. Reverse tran-
scription reactions for let-7b, let-7c, miR-3473, miR-23b, miR-200b and
cel-miR-39 were performed with 3 ng of total RNA using Taqman
MicroRNA Reverse Transcription Kit (ThermoFisher Scientific) ac-
cording to the manufacturer's directions. qPCR was carried out with
Taqman Gene Expression Master Mix (2×) (ThermoFisher Scientific)
and TaqMan gene expression assays (let-7b, #000378; let-7c, #000379;
miR-3473, #475642_mat; miR-23b, #000400; miR-200b, #001800;
cel-miR-39, #000200) using cDNA in a 10 μL reaction volume. The cel-
miR-39 was used to normalize miRNA expression; 1 nM of a 5′-phos-
phorylated sequence (#478293_mir) was spiked into each cDNA
synthesis reaction.
qPCR reactions were performed in the ABI 7500 qPCR system
(Applied Biosystems, Santa Clara, CA, USA). qPCR efficiency was cal-
culated by linear regression from fluorescence increase in the ex-
ponential phase in the LinRegPCR software v11.1 [20]. The comparison
of urine EV miRNA expression between LabSand and metabolic cage
was determined following normalization with cel-miR-39. The relative
microRNA expression was measured by using the comparative CT
method [21].
2.5. Statistics
All comparisons between metabolic cage and LabSand urine col-
lection methods were performed by paired t-test (EV size, EV con-
centration, and total RNA) or unpaired t-test (all 5 PCR validations due
to lack of enough volume for a few samples to complete the pair) using
GraphPad Prism Software (version 8.01, La Jolla, CA, USA). P values
less than 0.05 were considered significant.
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3. Results
3.1. Characterizing extracellular vesicles
Exosomes are typically 50–150 nm in diameter [3,5]. Extracellular
vesicles in our samples had a size range between 15 and 345 nm, with
the largest peaks falling within 41–160 nm, as can be seen in the size
spectrum analysis in Fig. 1A. There were no significant differences
between characteristics of EVs isolated from urine collected with the
metabolic cage (MC) method versus the LabSand (LS) method. The size
of the particles extracted from the MC urine samples were not sig-
nificantly different from the size of the particles extracted from the LS
urine samples (Fig. 1A, entire particle size distribution: MC mean
122 nm, STD 6.46, min 114, max 134; LS mean 125 nm, STD 9.69, min
107, max 136; t7= 0.8685, p= .4139). Similarly, the particle con-
centration (number of particles per mL of urine) was not significantly
different between the two urine collection methods (Fig. 1B: MC mean
1.27×1012 particles/mL, STD 0.553×1012, min 6.0×1011, max
1.9×1012; LS mean 1.79× 1012 particles/mL, STD 1.18×1012, min
4.0×1011, max 3.9× 1012 t7= 1.871, p= .1035). Further, total RNA
collected from the EVs was also not significantly different between
urine from the two methods (Fig. 1C: MC mean 344 ng/μl, STD 80.7,
min 257, max 513; LS mean 369 ng/μl, STD 59.9, min 290, max 477;
t7= 0.6986, p= .5073). For all samples, the bioanalyzer electro-
pherogram showed a single peak at the 25 nt location, indicating that
the type of RNA in EVs collected from urine samples were primarily
Fig. 1. Extracellular vesicles (EVs) isolated from urine samples collected by either metabolic cage (MC) or LabSand (LS) urine collection methods were characterized
for their (A) size, (B) particle concentration, (C) total RNA, and type and abundance of miRNAs expressed in the EVs to determine whether the LabSand urine
collection method resulted in similar quantity and quality of EV collection as the traditional metabolic cage urine collection method. Relative expression of the top
five miRNAs determined by microarray were verified by qPCR (D). Data is presented as the mean± SEM.
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miRNAs. It is also important to note that without the presence of rRNA,
there is no RIN value to indicate quality of RNA extracted beyond the
size peak.
3.2. qPCR validation of top 5 most abundant miRNA
To perform a “survey” analysis of the identification and relative
abundance of the miRNAs present within the EVs, all 8 individual rat
session-pooled samples were further pooled within each urine collec-
tion method and assayed via miRNA microarray (n=1 for each col-
lection method). This data is not shown, since it is just a list of abundant
miRNAs, although the list is in the same order for both collection
methods. The top 5 most abundant miRNAs as determined by micro-
array were validated by qPCR, going back to the 8 individual rat ses-
sion-pooled samples (n=7 for metabolic sand, n=6 for lab sand due
to not enough leftover volume for verification). Samples were analyzed
by qPCR for expression of miR-3473, let-7c-5p, let 7b-5p, miR-200b-3p,
and miR-23b-3p. Expression was normalized to a spike of cel-miR-39.
There were no statistically significant differences in the level of ex-
pression (arbitrary units, AU) for any of these miRNAs between samples
collected from the MC method compared to the LS method (Fig. 1D; see
Table 1 for mean, STD, and statistical results).
4. Discussion
We have previously shown that a hydrophobic sand material is a
suitable alternate method for urine collection in the rat compared to the
traditional metabolic cage because it does not increase stress or stress
markers in the rats, nor does it contaminate or otherwise alter normal
clinical urinary markers or the concentration of various metals. Here we
wanted to take this a step further and determine whether the hydro-
phobic sand compromised the quantity or quality of EVs, and their
miRNA cargo, which could be collected from rat urine samples com-
pared to the use of the metabolic cage method. We found no significant
differences in particle size or concentration, total RNA collected, or the
types and abundance of miRNAs contained within urine EVs due to
urine collection method. It is interesting to note that of the most
abundant miRNAs detected in EVs isolated from these urine samples,
three (let-7c, miR-23b and miR-200c) are associated with kidney
function [22–25]. The let-7 family is known to be highly abundant in
different bodily fluids with let-7b being a proposed as a potential bio-
marker for kidney disease [26]. miRNA-3473 was the most abundant
urine miRNA detected in the current study and has been reported to be
associated with renal tubular injury [27]. We conclude that the use of
hydrophobic sand in the collection of rodent urine for studies of
changes in EVs as biomarkers of kidney health will not compromise the
quality of the miRNAs examined, and is thus an acceptable alternate
method of urine collection for an even broader range of studies.
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